A clinical trial supported by the National Institutes of Health (NIH) is testing an experimental treatment designed to help people suffering the effects of dengue, a mosquito-borne viral disease.
A nasal vaccine for COVID-19—based on technology developed at Washington University in St. Louis—is poised to enter a phase 1 ...
A House committee will hold a hearing this week scrutinizing whether National Institutes of Health animal research amounts to ...
SAN DIEGO - Dare Bioscience, Inc. (NASDAQ: DARE), a biopharmaceutical company focused on women's health, has been awarded a Notice of Award of a grant from the National Institute of Allergy and ...
A recent paper published in Science magazine by researcher Blanca Barquera, Ph.D., professor of biological sciences at ...
A newly released document reveals that the US government, under the Biden administration, allocated over $40 million in ...
Goodman also blamed "institutional inertia" and "circular reasoning" – that agencies had always experimented on animals – for not innovating outside animals, while Locke said feds were "passive and ...
Mass General Brigham researchers discovered a previously unknown mechanism that may drive tissue damage and a new target for drug discovery ...
Ky., issued subpoenas to 14 agencies from the outgoing Biden administration in his effort to continue investigating the ...
Our immune system is armed with an array of defenses designed to detect and eliminate harmful threats. One of its most powerful defense mechanisms is ...